Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Saliva Diagnostics (SALV) -- Ignore unavailable to you. Want to Upgrade?

To: RSH who wrote (3246)	10/26/1999 10:59:00 AM
From: Bruce Rozenblit	Respond to of 3369

That was almost 2 years ago. Since then I've learned that the FDA does not support on site, instant Aids testing because the CDC wants to track the carriers. That means the drug companies can't make any money off of the test. This does not work in the real world because about 50% of the people that come into clinics to get tested never come back to get the results. It's a lot of political bullshit. The best market is overseas in Asia and Africa where the disease is rampant but those countries are broke. By the way, Salv was supposed to have developed and H. Pylori (ulcer bacteria) test that was approved. Where is it?

To: RSH who wrote (3246)	10/29/1999 5:16:00 PM
From: RSH	Read Replies (3) \| Respond to of 3369

(.21 X .25) To All: THE NEW SALV is primed for positive action in November! 1) Get ready for SALV's new website to be up and running any day now. 2) Very promising news releases will hit in the next few weeks. 3) The lead investors of SALV (Tailwind Fund) have the exact same interests as the common shareholders. They are interested in bringing value to SALV shares. 4) Consultants have been hired by the lead investors in order to clean up SALV's past financial obligations in order to build a platform to market SALV's rapid tests worldwide. Day in and day out, the consultants are striving to make SALV whistle clean so that the shareholders get the run for their money that they deserve. If you have any questions, call SALV at (360) 696-4800, extension 23 and speak with John Flynn. He's knowledgeable, articulate, and informative regarding the new SALV's potential. 5) Leo Ehrlich and the new management are committed to turn SALV around. They are qualified and very capable to execute the new business plan. 6) Once everyone sees the forthcoming news releases and does their DD on the new management, it will be obvious that this is a very determined, dedicated, and ethical group of people. 7) Whether the new SALV becomes primed for a buyout or turnaround, we are about to see a drastic increase in share price. BASHERS BEWARE: When the new website is launched and the forthcoming news is released, hopefully you will finally realize that I know what I'm talking about. It may be time for the bashers to buy some shares immediately because these low prices will be unattainable in the next few trading days beginning November 1! THIS IS NOT THE SAME SALIVA DIAGNOSTICS YOU BASHERS ONCE KNEW AND HAVE COME TO LOATHE!!!! Out with the old, and in with the NEW $ALV!!!! RSH